The Latest Cardiac and Vascular News
Successfully Met Primary and Secondary Endpoints, with Mean Placebo-Adjusted Reduction in Systolic Blood Pressure of 9.7 mmHg in Uncontrolled and Resistant Hypertensive Subjects at 50 mg Once Daily (p=0.01 vs. placebo) Subjects Using a Thiazide Diuretic (Approximately Half of the Study Population) Showed a Mean Placebo-Adjusted Reduction in Systolic Blood […]
The first real-world biometrics data platform for continuous and episodic remote patient monitoring now supports Roche, OMRON, Garmin, and other wearable medical devices to power virtual healthcare applications. CAMPBELL, Calif., Nov. 16, 2022 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, announces physiological data from a wide range of the world’s leading […]
CardieX’s comprehensive suite of heart health solutions to be enhanced by Blumio’s next-generation cardiovascular wearable sensor algorithms and data analytics tools IRVINE, Calif., Nov. 15, 2022 /PRNewswire/ — CardieX Limited (ASX: CDX), a global health technology company focused on cardiovascular disease, today announced that it has acquired all the assets of Blumio, Inc., a Silicon Valley […]
Independent study demonstrates novel AI-ECG algorithm could provide a cost-effective strategy for improving cardiac risk stratification Southlake, Texas, Nov. 10, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as […]
The mobile and web app provides quick access to common and challenging echocardiography measurements and values DURHAM, NC, Nov. 09, 2022 (GLOBE NEWSWIRE) — The American Society of Echocardiography (ASE) announced today that it is launching a new interactive mobile and web application for healthcare professionals providing cardiac care. EchoGuide™ is a calculator and […]
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc. announces the successful first-in-human study of its next generation Globe® Pulsed Field System to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy. Working with Dr. Vivek Reddy1 from Mount Sinai Hospital (New York, USA), and Prof. Petr Neužil and Dr. Jan Petrů from Na Homolce […]
Aprocitentan is an investigational antihypertensive drug with a novel mechanism of action RARITAN, N.J., Nov. 7, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with Idorsia Ltd, today announced results from the Phase 3 PRECISION study, which found aprocitentan, an investigational, novel dual endothelin receptor antagonist (ERA), […]
Compiled Data from RADIANCE Global Program Show Consistent Treatment Effect and Safety Across Broad Patient Population PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. today announced consistent and significant blood pressure (“BP”) lowering results across a range of patients with uncontrolled hypertension, including across […]
Primary endpoint was not met for the modified intent-to-treat (mITT) population; however, clinical benefit observed in coronary artery bypass graft (CABG) patients Data showed relative risk reduction in specific study populations and overall lower rates of rehospitalization within 30 days compared to placebo Adverse Events (AEs) were numerically similar across […]
Data Demonstrate Orally Inhaled Flecainide May Provide a Safe, Effective, and Convenient First-Line Treatment Option for Cardioversion of Recent-Onset Newly Diagnosed and Paroxysmal Atrial Fibrillation Topline Results from the Ongoing Pivotal Phase 3 RESTORE-1 Trial of InRhythm Expected in Early 2024 SAN FRANCISCO, Nov. 07, 2022 (GLOBE NEWSWIRE) — InCarda […]
